Argonne Center for Nanoscale Materials staff in the Nanofabrication & Devices Group together with collaborative users from the University of Wisconsin-Milwaukee have fabricated a miniaturized gas sensor using hybrid nanostructures consisting of SnO2 nanocrystals supported on multiwalled carbon nanotubes.
Researchers have demonstrated that, counter to classical Newtonian mechanics, an entire collection of superconducting electrons in an ultrathin superconducting wire is able to 'tunnel' as a pack from a state with a higher electrical current to one with a notably lower current, providing more evidence of the phenomenon of macroscopic quantum tunneling.
Over 170 businesses, research groups and other organizations are involved in the emerging field of synthetic biology throughout the United States, according to a new interactive map launched today by the Synthetic Biology Project at the Woodrow Wilson Center.
Rice University researchers today announced that the first field tests of 'nanorust', the university's revolutionary, low-cost technology for removing arsenic from drinking water, will begin later this year in Guanajuato, Mexico.
In the second call for proposals, projects focus on either the development of new technologies or on the interface between biomedical research and genomics. The Swiss National Science Foundation (SNSF) approved six RTD-projects today.
A first-of-its-kind clinical trial exploring a way to diagnose cancer in its earliest stages is being conducted at the UAMS Winthrop P. Rockefeller Cancer Institute through a National Cancer Institute grant.
Rice physicist Huey Huang is on a quest to understand death -- or at least a little piece of it. Huang has spent the past 15 years studying the properties of cell membranes in an effort to unravel a mystery about cell suicide, a mystery that starts with a tiny hole.
The Wroclaw Research Center, European Institute of Technology Plus (WRC EIT+) and IBM (NYSE: IBM) have agreed today to collaborate on the advancement of scientific research, graduate education and technological development in fundamental and applied sciences.
Scientists are reporting a potential solution to a problem that limits the human body's ability to absorb and use medications for heart disease, Type-2 diabetes, cancer and other conditions. It is a 'nano-hybrid microcapsule' that enables the stomach to absorb more of these so-called 'poorly-soluble' medicines.
Scientists are reporting discovery of a potential new alternative to aspirin, ReoPro, and other anti-platelet agents used widely to prevent blood clots in coronary artery disease, heart attack and stroke.
In collaboration with the Chinese Academy of Sciences in Beijing, scientists have investigated the rotation of molecules on a fixed surface to understand how they may help in the development of future rotor-based machinery at nanoscale level.